Centene Corporation
NYSE:CNCMedical - Healthcare Plans
+$0.67 today
- Market cap
- $33.39B
- Beta
- 1.09
- P/E (TTM)
- -4.7
- EPS (TTM)
- -$13.09
Volume 6.29M
Average 6.16M
CNC Total Current Liabilities
All obligations due within one year.
Centene CorporationNYSE: CNC
Total Current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total current liabilities rises 10.8% from a year ago
Total current liabilities stood at $40.76B at the end of Q2 FY2026, up 10.8% from a year earlier and up 1.8% from the prior quarter. Over 3 fiscal years it compounded at -9.0% a year.
Context
- Total current liabilities amounted to 49.1% of total assets at the end of Q2 FY2026, up 6.5 pp from a year earlier.
- Total current liabilities increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +10.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 21.48B USD
- Year-over-year change
- -37.3%
- 4-year CAGR
- -4.4%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 21.48B | -37.3% |
| FY2024 | 2024-12-31 | 34.26B | -6.7% |
| FY2023 | 2023-12-31 | 36.72B | +29.0% |
| FY2022 | 2022-12-31 | 28.46B | +10.5% |
| FY2021 | 2021-12-31 | 25.77B | — |
Total Current Liabilities vs competitors
How CNC compares with its peers on the latest reported figures
- CNC's Jun 2026 total current liabilities of $40.76B is the 5th highest of the 9 companies compared; the peer median is $35.36B.
- Its year-over-year change of +10.8% is the 5th highest of 9, against a peer median of +21.9%.
- Total current liabilities amounts to 49.1% of total assets for CNC, versus a peer median of 39.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $115.84B | +0.3% | +8.8% | 37.0% | |
| Jun 2026 | $87.04B | -7.6% | +8.5% | 34.3% | |
| Sep 2026 | $56.03B | -0.7% | +11.0% | 35.5% | |
| Sep 2026 | $46.66B | +158.1% | +2.3% | 36.5% | |
| Jun 2026 | $40.76B | +10.8% | -9.0% | 49.1% | |
| Sep 2026 | $24.05B | +132.3% | -3.9% | 42.0% | |
| Jun 2026 | $8.69B | +78.6% | +17.9% | 77.4% | |
| Sep 2026 | $7.39B | -1.2% | +2.5% | 47.2% | |
| Mar 2026 | $655.97M | +43.5% | +27.5% | 52.0% | |
| Peer median (excluding CNC) | $35.36B | +21.9% | +8.6% | 39.5% | |
Competitors are the stored peer set for CNC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 13.12B | 12.07B | 17.19B | 14.06B | 17.89B |
| Short-term Investments | 1.54B | 2.32B | 2.46B | 2.62B | 0 |
| Net Receivables | 12.24B | 13.27B | 15.53B | 19.71B | 18.11B |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 1.6B | 2.46B | 5.57B | 1.6B | 0 |
| Total Current Assets | 28.5B | 30.13B | 40.76B | 38B | 35.99B |
| Property, Plant & Equipment (Net) | 6.96B | 4.99B | 2.42B | 2.43B | 2.35B |
| Goodwill | 19.77B | 18.81B | 17.56B | 17.56B | 10.84B |
| Intangible Assets | 7.82B | 6.91B | 6.1B | 5.41B | 4.53B |
| Long-term Investments | 14.04B | 14.68B | 16.29B | 17.43B | 20.88B |
| Tax Assets | 0 | 0 | 0 | 0 | 914M |
| Other Non-current Assets | 1.28B | 1.35B | 1.53B | 1.62B | 2.16B |
| Total Non-current Assets | 49.88B | 46.74B | 43.89B | 44.45B | 41.67B |
| Total Assets | 78.38B | 76.87B | 84.64B | 82.45B | 77.66B |
| Account Payables | 8.29B | 9.35B | 16.25B | 13.02B | 20.54B |
| Short-term Debt | 267M | 82M | 119M | 110M | 196M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 434M | 478M | 715M | 661M | 736M |
| Other Current Liabilities | 14.24B | 16.75B | 18B | 18.31B | (50M) |
| Total Current Liabilities | 25.77B | 28.46B | 36.72B | 34.26B | 21.48B |
| Long-term Debt | 18.57B | 17.94B | 17.71B | 18.42B | 17.97B |
| Deferred Tax Liabilities | 1.41B | 615M | 641M | 684M | 1.75B |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.99B | 2.48B | 2.74B | 1.83B | 15.8B |
| Total Non-current Liabilities | 25.59B | 24.17B | 21.97B | 21.67B | 36.13B |
| Total Liabilities | 51.35B | 52.63B | 58.69B | 55.94B | 57.61B |
| Common Stock | 1M | 1M | 1M | 1M | 1M |
| Retained Earnings | 8.14B | 9.34B | 12.04B | 15.35B | 8.67B |
| Accumulated OCI | 77M | (1.13B) | (652M) | (504M) | (58M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 227M | 180M | 116M | 100M | 103M |
| Total Equity | 27.02B | 24.24B | 25.96B | 26.51B | 20.06B |
| Total Debt | 22.66B | 21.33B | 18.88B | 19.43B | 18.78B |
| Net Debt | 9.54B | 9.26B | 1.68B | 5.37B | 889M |
Centene Corporation
NYSE:CNC
Intrinsic Alpha fair value
Locked
Current Price
$67.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.